Peer-reviewedCC BY 4.0Frontiers in Oncology
Editorial: E3 ubiquitin ligases: critical roles in cancer progression and therapeutic implications
- 1Cancer Genome and Epigenetics Program, Sanford Burnham Prebys Medical Discovery Institute
- 2Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
- 3Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill
Related
- NEDD4 Promotes Hepatocellular Carcinoma Progression Through Ubiquitin-Dependent Degradation of EPHB6.
- Ubiquitin-conjugating enzyme E2S promotes the progression of lung adenocarcinoma through the NF-κB/GATM signaling axis
- Ubiquitin-specific proteases and the immune microenvironment in cervical cancer: mechanistic evidence, immunotherapy resistance, and therapeutic perspectives
- Editorial: Decoding the gut-brain axis: implications for neurodegenerative disease therapies
- Editorial: The role of RNA regulation in cancer pathogenesis and therapeutic strategies
BibTeX
@article{koganti2026editorial,
title = {{Editorial: E3 ubiquitin ligases: critical roles in cancer progression and therapeutic implications}},
author = {Praveen Koganti and Pengda Liu},
journal = {Frontiers in Oncology},
year = {2026},
month = oct,
doi = {10.3389/fonc.2026.1995835},
url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1995835/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Editorial: E3 ubiquitin ligases: critical roles in cancer progression and therapeutic implications
AU - Praveen Koganti
AU - Pengda Liu
PY - 2026
DA - 2026/10/01
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.1995835
UR - https://www.frontiersin.org/articles/10.3389/fonc.2026.1995835/full
SN - 2234-943X
ER -